These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17329491)

  • 1. Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia.
    Siempos II; Vardakas KZ; Manta KG; Falagas ME
    Eur Respir J; 2007 Mar; 29(3):548-60. PubMed ID: 17329491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
    Jenkins SG; Fisher AC; Peterson JA; Nicholson SC; Kaniga K
    Curr Med Res Opin; 2009 Dec; 25(12):3029-36. PubMed ID: 19849650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
    Koulenti D; Rello J
    Expert Opin Pharmacother; 2006 Aug; 7(12):1555-69. PubMed ID: 16872259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia.
    Scaglione F; Esposito S; Leone S; Lucini V; Pannacci M; Ma L; Drusano GL
    Eur Respir J; 2009 Aug; 34(2):394-400. PubMed ID: 19213786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic resistance patterns in Acinetobacter spp. strains isolated from hospital environment].
    Văduva DB; Muntean D; Lonescu G; Licker M; Văduva MB; Velimirovici D; Rădulescu M; Dumitraşcu V; Crăciunescu M; Dugăeşescu D; Horhat F; Piluţ C; Bădiţoiu L; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):103-7. PubMed ID: 19856849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of hospital death in nosocomial infection with multi-drug resistant A. baumanii or P. aeruginosa].
    Ion-Nedelcu N; Lambru K; Luminiţa R; Manta C
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(1):29-33. PubMed ID: 21038702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the treatment of Pseudomonas aeruginosa pneumonia.
    El Solh AA; Alhajhusain A
    J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
    DeRyke CA; Kuti JL; Nicolau DP
    Pharmacotherapy; 2007 Mar; 27(3):333-42. PubMed ID: 17316145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
    Goyal K; Gautam V; Ray P
    Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.